NT157
NT157, a selective inhibitor of IRS-1/2(insulin receptor substrate), has the potential to inhibit IGF-1R and STAT3 signaling pathways in cancer cells and stroma cells of TME leading to a decrease in cancer cell survival.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | S8228 |
| Sku # | S8228-25mg |
| Pricing | 25mg, $670.00 |
Citations for this product:
-
bioRxiv - Immunology 2022Quote: ... cells were first treated with an IRS-1/2 inhibitor (S8228, 5um, Selleck Chemicals), an mTOR inhibitor (S2827 ...